E-GEOD-40383 - Prostate cancer cell lines: non-targeting siRNA versus SChLAP1-siRNA treated

Status
Released on 20 July 2013, last updated on 2 June 2014
Organism
Homo sapiens
Samples (24)
Array (1)
Protocols (7)
Description
SChLAP1 is a novel long non-coding RNA expressed in prostate cancer. Here we performed transcriptional profiling of the prostate cancer cell lines LNCaP and 22Rv1 comparing non-targeting siRNA treatment versus SChLAP1-siRNA treatment. Goal was to determine the effect of SChLAP1 knockdown on gene expression in prostate cancer. Two-condition experiment: non-targeting siRNA versus SChLAP1 siRNA treated cells. Biological replicates: 1 control replicate, 2 treatment replicates. Technical replicates: 3 replicates per SChLAP1 siRNA. Cell lines: 22Rv1 and LNCaP.
Experiment type
transcription profiling by array 
Contacts
Matthew Iyer <mkiyer@med.umich.edu>, John R Prensner, Matthew K Iyer, Xiaojung Jing
MIAME
PlatformsProtocolsFactorsProcessedRaw
Files
Investigation descriptionE-GEOD-40383.idf.txt
Sample and data relationshipE-GEOD-40383.sdrf.txt
Raw data (1)E-GEOD-40383.raw.1.zip
Processed data (1)E-GEOD-40383.processed.1.zip
Array designA-AGIL-28.adf.txt
Links